期刊文献+

后循环缺血介入治疗50例临床分析 被引量:2

Interventional Therapy of Posterior Circulation Ischemia:A Clinical Study of 50 Cases
下载PDF
导出
摘要 目的分析50例后循环缺血病人脑血管造影表现、血管内治疗方法及治疗效果。方法短暂性脑缺血发作(TIA)25例,梗死组25例,根据造影显示的血管病变情况行选择性动脉溶栓或支架置入术治疗。结果TIA溶栓15例,1个月内再发2例,6个月后梗死1例;TIA支架10例,1个月内再发1例,6个月后无再狭窄发生。梗死溶栓25例,均取得明显疗效;支架治疗8例,6个月后无再狭窄发生。50例均无颅内出血等相关并发症或死亡发生。结论①采用动脉内溶栓及支架治疗后循环缺血具有较好疗效;②TIA应与急性脑梗死一样得到同等重视,积极检查和治疗;③中药可能在减少再灌注损伤以及减少支架后再狭窄方面发挥一定作用。 Objective To discuss the methods and clinical efficacy of interventional therapy for posterior circulation ischemia, Methods There were patients(pts) with TIA pts and 25 pts with stroke. According to the results of DSA, the received the therapy of selective in- tra-arterial thrombolysis(SIT) or percutaeous transluminal angioplasty(PTA), Results 15 pts with TIA received the therapy of SIT, Two pts relapsed within one month. 1 case got stroke after 6 months. Tin pts with TIA received the therapy of PTA. One case relapsed within 1 month. All 25 pts with stroke received the therapy of SIT and got good curative effect. Eight pts cases received the therapy of PTA. There were no restenosis after 6 months and no procedural and peri - procedural complications, Conclusion The therapy of SIT and PTA was an effective method in the treatment of vertebrobasilar ischemia, attention to TIA like stroke. Chinese medicine might be probably useful to reduce hyperperfusion and restenosis.
出处 《中西医结合心脑血管病杂志》 2007年第11期1060-1062,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 椎-基底动脉 缺血性卒中 短暂性脑缺血发作 动脉溶栓 支架 vertebrobasilar artery ischemic stroke transient ischemie attack intra- arterial thrombolysis stent
  • 相关文献

参考文献11

二级参考文献55

  • 1史大卓,李静,马晓昌,张群豪,毛节明,陈明哲,陈可冀.血府逐瘀浓缩丸预防冠心病病人经皮冠状动脉腔内成形术后再狭窄的临床观察[J].中医杂志,1997,38(1):27-29. 被引量:61
  • 2中国中西医结合研究会活血化瘀专业委员会.血瘀证诊断标准[J].中西医结合杂志,1987,(3):129-129.
  • 3王阶.血瘀证诊断标准的研究[A].见:陈可冀主编.活血化瘀研究与临床[C].北京:北京医科大学中国协和医科大学联合出版社,1993.7.
  • 4中国中西医结合学会心血管病学会.冠心病中医诊断标准.中西医结合杂志,1991,11(5):257-257.
  • 5Rayn TJ,Faxon DP,Gunnar RM,et al.Guidelines for percutaneous transluminal coronary angioplasty:A report of the American College of Cardiology American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).J Am Coll Cardiol 1988; 12:529.
  • 6Ellis SG,Vandormael MG,Cowley M J,et al.Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease.Implications for patient selection.Circulation 1999 ;82:1193.
  • 7Degertekin M,Serruys PW,Foley DP,et al.Persistant inhi bition of neointimal hyperplasia after sirolimus-eluting stent implantation:long term (up to 2 years) clinical,angiographic,and intravascular ultrasound follow-up.Circulation 2002; 106:1610-1613.
  • 8Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med 2002; 346:1773-1780.
  • 9Waksman R.Drug-eluting stents:from bench to bed.Cardiovasc Radiat Med 2002; 3 (3-4):226-241.
  • 10Froeschl M,Olsen S,Ma X,et al.Current understanding of in-stent restenosis and the potential benefit of drug eluting stents.Curt Drug Targets Cardiovasc Haematol Disord 2004;4(1):103-117.

共引文献1379

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部